ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 13317 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 13317; 2) Community: the network communities that were significantly associated with the response to NSC 13317; 3) Molecule: the relationships between components within communities and NSC 13317; 4) MDR: the compounds that were significantly associated with the NSC 13317.

NSC Compound Enrichment Correlation
NSC 746035 2-4-[(5-2,6-dimethoxy-4-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-3-isoxazolyl]phenoxypentyl)oxy]-3-methoxyphenyl-1,2,3,4-tetrahydro-4-quinazolinone 0.00295310816022625 0.12509076
NSC 749117 3-(2-Hydroxy-4-methoxyphenyl)-5-(4-methoxyphenyl)-1-(4-sulfamylphenyl)-2-pyrazoline 0.00295310816022625 0.41116006
NSC 75890 1,9-Pyrazoloanthrone 0.00295310816022625 0.0074732553
NSC 149286 1,4-Pentadien-3-one, 1,5-di-3-pyridyl- 0.00313644776247642 0.43871768
NSC 26074 Null 0.00313644776247642 0.59252289
NSC 274539 Olivomycin D, 3B-O-(2,6-dideoxy-3-C-methyl-L-arabinohexopyranosyl)- 0.00313644776247642 0.29570241
NSC 622398 Fascaplysine 0.00313644776247642 0.41265437
NSC 648148 Null 0.00313644776247642 0.30803923
NSC 658798 Null 0.00313644776247642 0.32100026
NSC 678637 Benzoic acid, 4-[[(3,6-dioxo-1,4-cyclohexadienyl)methyl]amino]-, tert-butyl ester 0.00313644776247642 0.37823693
Total:70  Current:6    [First] [Prev] [Next] [Last]